| Literature DB >> 25289806 |
Maximiliaan Schillebeeckx1, Marjut Pihlajoki2, Elisabeth Gretzinger3, Wei Yang1, Franziska Thol3, Theresa Hiller3, Ann-Kathrin Löbs3, Theresa Röhrig3, Anja Schrade2, Rebecca Cochran4, Patrick Y Jay5, Markku Heikinheimo2, Robi D Mitra1, David B Wilson6.
Abstract
Gonadectomy (GDX) induces sex steroid-producing adrenocortical tumors in certain mouse strains and in the domestic ferret. Transcriptome analysis and DNA methylation mapping were used to identify novel genetic and epigenetic markers of GDX-induced adrenocortical neoplasia in female DBA/2J mice. Markers were validated using a combination of laser capture microdissection, quantitative RT-PCR, in situ hybridization, and immunohistochemistry. Microarray expression profiling of whole adrenal mRNA from ovariectomized vs. intact mice demonstrated selective upregulation of gonadal-like genes including Spinlw1 and Insl3 in GDX-induced adrenocortical tumors of the mouse. A complementary candidate gene approach identified Foxl2 as another gonadal-like marker expressed in GDX-induced neoplasms of the mouse and ferret. That both "male-specific" (Spinlw1) and "female-specific" (Foxl2) markers were identified is noteworthy and implies that the neoplasms exhibit mixed characteristics of male and female gonadal somatic cells. Genome-wide methylation analysis showed that two genes with hypomethylated promoters, Igfbp6 and Foxs1, are upregulated in GDX-induced adrenocortical neoplasms. These new genetic and epigenetic markers may prove useful for studies of steroidogenic cell development and for diagnostic testing.Entities:
Keywords: Adrenal cortex; Endocrine tumor; Gonadotropin; Ovariectomy; Steroidogenesis
Mesh:
Substances:
Year: 2014 PMID: 25289806 PMCID: PMC4262703 DOI: 10.1016/j.mce.2014.09.029
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102